Literature DB >> 17045620

Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.

Carrie K Jones1, Brian J Eastwood, Anne B Need, Harlan E Shannon.   

Abstract

The efficacy of antidepressant drugs with serotonergic, noradrenergic, or dual reuptake inhibition was evaluated in reversing carrageenan-induced thermal hyperalgesia and mechanical allodynia in rats. Duloxetine (1-30mg/kg, i.p.), a balanced serotonergic-noradrenergic reuptake inhibitor (SNRI), was equiefficacious and more potent than the SNRI venlafaxine (3-100mg/kg, i.p.) in reversing both thermal hyperalgesia and mechanical allodynia induced by carrageenan. In addition, the selective noradrenergic reuptake inhibitors (NRIs) thionisoxetine (0.03-10mg/kg, i.p.) and desipramine (1-30mg/kg, i.p.) also produced complete reversals of carrageenan-induced thermal hyperalgesia. However, only thionisoxetine exhibited a greater than 80% reversal of the carrageenan-induced mechanical allodynia. In contrast, the selective serotonergic reuptake inhibitors (SSRIs) paroxetine, sertraline, and fluoxetine (0.3-10mg/kg i.p.) had little or no effect in the carrageenan model. In order to understand whether the observed enhanced effectiveness of the dual SNRIs was due to a possible synergism between serotonergic and noradrenergic reuptake inhibition, the effects of the NRI thionisoxetine alone and in combination with an inactive dose of the SSRI fluoxetine were determined. In the presence of fluoxetine, the potency of thionisoxetine in reversing carrageenan-induced hyperalgesia and allodynia was significantly increased by approximately 100-fold and brain concentrations of thionisoxetine were increased by 1.1- to 5-fold. The present data indicate fluoxetine pharmacodynamically potentiated the analgesic effects of thionisoxetine over and above a metabolic interaction between these two drugs. The present findings thus indicate that, in the carrageenan model, dual serotonergic-noradrenergic reuptake inhibition by dual SNRIs, or SSRI-NRI combinations, produces synergistic analgesic efficacy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17045620     DOI: 10.1016/j.neuropharm.2006.08.005

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  9 in total

1.  Discovery of a potent, dual serotonin and norepinephrine reuptake inhibitor.

Authors:  Nicolas Dreyfus; Jason K Myers; Valentina O Badescu; Oscar de Frutos; Maria Luz de la Puente; Chunjin Ding; Sandra A Filla; Karsten Fynboe; Douglas L Gernert; Beverly A Heinz; Susan K Hemrick-Luecke; Kirk W Johnson; Michael P Johnson; Pilar López; Patrick L Love; Laura J Martin; Thierry Masquelin; Michael J McCoy; Javier Mendiola; Denise Morrow; Mark Muhlhauser; Gustavo Pascual; Thomas J Perun; Lance A Pfeifer; Lee A Phebus; Simon J Richards; Juan Antonio Rincón; Eric P Seest; Jikesh Shah; Jia Shaojuan; Rosa Maria A Simmons; Gregory A Stephenson; Eric G Tromiczak; Linda K Thompson; Magnus W Walter; Wayne W Weber; Hamideh Zarrinmayeh; Craig E Thomas; Elizabeth Joshi; Smriti Iyengar; Anette M Johansson
Journal:  ACS Med Chem Lett       Date:  2013-05-07       Impact factor: 4.345

Review 2.  Fibromyalgia and sleep in animal models: a current overview and future directions.

Authors:  Cristina Frange; Camila Hirotsu; Helena Hachul; Paula Araujo; Sergio Tufik; Monica L Andersen
Journal:  Curr Pain Headache Rep       Date:  2014

Review 3.  Psychiatric issues in chronic pain.

Authors:  Michael R Clark
Journal:  Curr Psychiatry Rep       Date:  2009-06       Impact factor: 5.285

4.  Disruption of 5-HT2A receptor-PDZ protein interactions alleviates mechanical hypersensitivity in carrageenan-induced inflammation in rats.

Authors:  Anne-Sophie Wattiez; Xavier Pichon; Amandine Dupuis; Alejandro Hernández; Anne-Marie Privat; Youssef Aissouni; Maryse Chalus; Teresa Pelissier; Alain Eschalier; Philippe Marin; Christine Courteix
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

Review 5.  Overview of Neurological Mechanism of Pain Profile Used for Animal "Pain-Like" Behavioral Study with Proposed Analgesic Pathways.

Authors:  Mun Fei Yam; Yean Chun Loh; Chuan Wei Oo; Rusliza Basir
Journal:  Int J Mol Sci       Date:  2020-06-19       Impact factor: 5.923

6.  Evaluation of Prophylactic and Therapeutic Effects of Tramadol and Tramadol Plus Magnesium Sulfate in an Acute Inflammatory Model of Pain and Edema in Rats.

Authors:  Dragana Srebro; Sonja Vučković; Aleksandar Milovanović; Katarina Savić Vujović; Milica Prostran
Journal:  Front Pharmacol       Date:  2018-11-16       Impact factor: 5.810

Review 7.  Neurobiology of depression: an integrated view of key findings.

Authors:  V Maletic; M Robinson; T Oakes; S Iyengar; S G Ball; J Russell
Journal:  Int J Clin Pract       Date:  2007-10-17       Impact factor: 2.503

8.  Relative contributions of norepinephrine and serotonin transporters to antinociceptive synergy between monoamine reuptake inhibitors and morphine in the rat formalin model.

Authors:  Fei Shen; Pamela R Tsuruda; Jacqueline A M Smith; Glenmar P Obedencio; William J Martin
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

9.  Antinociceptive Effects of the Serotonin and Noradrenaline Reuptake Inhibitors Milnacipran and Duloxetine on Vincristine-Induced Neuropathic Pain Model in Mice.

Authors:  Soh Katsuyama; Hiromu Aso; Akira Otowa; Tomomi Yagi; Yukinaga Kishikawa; Takaaki Komatsu; Tsukasa Sakurada; Hitoshi Nakamura
Journal:  ISRN Pain       Date:  2014-02-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.